Relationship between N-terminal pro-B-type natriuretic peptide and renal function: The effects on predicting early outcome after off-pump coronary artery bypass surgery

Korean Journal of Anesthesiology

Volumn 61, Issue 1, 2011, Pages 35-41

  Jo, Youn Yi ^a   Kwak, Young Lan ^b   Lee, Jonghoon ^b   Choi, Yong Seon ^b  

^a Gachon University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

NT probnp; OPCAB; Renal function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACCURACY; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART VENTRICLE FAILURE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 80051775501     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2011.61.1.35     Document Type: Article

References (24)

1. Youn YN, Chang BC, Hong YS, Kwak YL, Yoo KJ. Early and midterm impacts of cardiopulmonary bypass on coronary artery bypass grafting in patients with poor left ventricular dysfunction: a propensity score analysis. Circ J 2007; 71: 1387-94.
2. Toumpoulis IK, Anagnostopoulos CE, DeRose JJ, Swistel DG. Early and mid-term outcome after off-pump coronary artery bypass grafting in patients with left ventricular dysfunction. Heart Surg Forum 2004; 7: E539-45.
3. Attaran S, Shaw M, Bond L, Pullan MD, Fabri BM. Does off-pump coronary artery revascularization improve the long-term survival in patients with ventricular dysfunction? Interact Cardiovasc Thorac Surg 2010; 11: 442-6.
4. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-16.
5. Kerbaul F, Collart F, Giorgi R, Oddoze C, Lejeune PJ, Guidon C, et al. Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery. Intensive Care Med 2004; 30: 1799-806.
6. Cuthbertson BH, Croal BL, Rae D, Gibson PH, McNeilly JD, Jeffrey RR, et al. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. Br J Anaesth 2009; 103: 647-53.
7. Choi EY, Ha JW, Joung B, Ko YG, Choi D, Rim SJ, et al. Effects of hemoglobin concentration and creatinine clearance in pro-B-type natriuretic peptide-based left ventricular filling pressure prediction in patients with preserved left ventricular systolic function. Am J Cardiol 2008; 101: 364-9.
8. Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, et al. Influence of renal function on the usefulness of Nterminal proB-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Am J Cardiol 2008; 101: 122-6.
9. Tsutamoto T, Wada A, Sakai H, Ishikawa C, Tanaka T, Hayashi M, et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006; 47: 582-6.
10. Kawai K, Hata K, Tanaka K, Kubota Y, Inoue R, Masuda E, et al. Attenuation of biologic compensatory action of cardiac natriuretic peptide system with aging. Am J Cardiol 2004; 93: 719-23.
11. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 2003; 89: 150-4.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-70.
13. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, Mass, Little, Brown & Co. 1994, pp 253-6.
14. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
15. Dupuis JY, Wang F, Nathan H, Lam M, Grimes S, Bourke M. The cardiac anesthesia risk evaluation score: a clinically useful predictor of mortality and morbidity after cardiac surgery. Anesthesiology 2001; 94: 194-204.
16. Weightman WM, Gibbs NM, Sheminant MR, Thackray NM, Newman MA. Risk prediction in coronary artery surgery: a comparison of four risk scores. Med J Aust 1997; 166: 408-11.
17. Martinez-Alario J, Tuesta ID, Plasencia E, Santana M, Mora ML. Mortality prediction in cardiac surgery patients: comparative performance of Parsonnet and general severity systems. Circulation 1999; 99: 2378-82.
18. Pons JM, Espinas JA, Borras JM, Moreno V, Martin I, Granados A. Cardiac surgical mortality: comparison among different additive risk scoring models in a multicenter sample. Arch Surg 1998; 133: 1053-7.
19. Orr RK, Maini BS, Sottile FD, Dumas EM, O'Mara P. A comparison of four severity-adjusted models to predict mortality after coronary artery bypass graft surgery. Arch Surg 1995; 130: 301-6.
20. Cuthbertson BH, Mc Keown A, Croal BL, Mutch WJ, Hillis GS. Utility of B-type natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery. Br J Anaesth 2007; 99: 170-6.
21. Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43: 1873-9.
22. Pfister R, Diedrichs H, Schiedermair A, Rosenkranz S, Hellmich M, Erdmann E, et al. Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients. Eur J Heart Fail 2008; 10: 315-20.
23. DeFilippi CR, Fink JC, Nass CM, Chen H, Christenson R. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis 2005; 46: 35-44.
24. Gutiérrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, et al. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clin Chem 2008; 54: 1339-48.